{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:05:52Z","timestamp":1762985152508,"version":"3.45.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jdin.2021.09.008","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T20:12:21Z","timestamp":1645560741000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cutaneous findings in myotonic dystrophy"],"prefix":"10.1016","volume":"7","author":[{"given":"Ha Eun","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian P.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0032-1329202","article-title":"Myotonic dystrophy: from bench to bedside","volume":"32","author":"Johnson","year":"2012","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"issue":"5049","key":"10.1016\/j.jdin.2021.09.008_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"issue":"5049","key":"10.1016\/j.jdin.2021.09.008_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu","year":"1992","journal-title":"Science"},{"issue":"5531","key":"10.1016\/j.jdin.2021.09.008_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"Meola","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.jdin.2021.09.008_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jmg.29.11.774","article-title":"The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy","volume":"29","author":"Hunter","year":"1992","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng0692-192","article-title":"Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy","volume":"1","author":"Tsilfidis","year":"1992","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib9","first-page":"154","article-title":"Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies","volume":"32","author":"Meola","year":"2013","journal-title":"Acta Myol"},{"issue":"10","key":"10.1016\/j.jdin.2021.09.008_bib10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/WNL.42.10.1877","article-title":"Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat","volume":"42","author":"Ashizawa","year":"1992","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jdin.2021.09.008_bib13","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biocel.2013.06.010","article-title":"Molecular mechanisms of muscle atrophy in myotonic dystrophies","volume":"45","author":"Timchenko","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"5364","key":"10.1016\/j.jdin.2021.09.008_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.280.5364.737","article-title":"Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy","volume":"280","author":"Philips","year":"1998","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.jdin.2021.09.008_bib15","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","article-title":"Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy","volume":"19","author":"Miller","year":"2000","journal-title":"EMBO J"},{"issue":"Spec No 2","key":"10.1016\/j.jdin.2021.09.008_bib16","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1093\/hmg\/ddl181","article-title":"RNA-dominant diseases","volume":"15","author":"Osborne","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.jdin.2021.09.008_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1083\/jcb.128.6.995","article-title":"Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues","volume":"128","author":"Taneja","year":"1995","journal-title":"J Cell Biol"},{"issue":"22","key":"10.1016\/j.jdin.2021.09.008_bib18","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","article-title":"Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy","volume":"24","author":"Timchenko","year":"1996","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jdin.2021.09.008_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/5.1.115","article-title":"Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy","volume":"5","author":"Timchenko","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.jdin.2021.09.008_bib20","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1074\/jbc.M005960200","article-title":"RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1","volume":"276","author":"Timchenko","year":"2001","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.jdin.2021.09.008_bib21","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1074\/jbc.M312923200","article-title":"Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis","volume":"279","author":"Timchenko","year":"2004","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.jdin.2021.09.008_bib22","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jdin.2021.09.008_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2017.08.039","article-title":"RAN Translation regulated by muscleblind proteins in myotonic dystrophy type 2","volume":"95","author":"Zu","year":"2017","journal-title":"Neuron"},{"issue":"5485","key":"10.1016\/j.jdin.2021.09.008_bib24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jdin.2021.09.008_bib25","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1172\/JCI64081","article-title":"GSK3\u03b2 mediates muscle pathology in myotonic dystrophy","volume":"122","author":"Jones","year":"2012","journal-title":"J Clin Invest"},{"volume":"10","year":"2001","author":"Seznec","key":"10.1016\/j.jdin.2021.09.008_bib26"},{"issue":"2","key":"10.1016\/j.jdin.2021.09.008_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1054\/bjps.1998.3036","article-title":"Multiple pilomatrixomata and myotonic dystrophy. A familial association","volume":"52","author":"Geh","year":"1999","journal-title":"Br J Plast Surg"},{"issue":"1","key":"10.1016\/j.jdin.2021.09.008_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/pde.13947","article-title":"Syndromes associated with multiple pilomatricomas: when should clinicians be concerned?","volume":"37","author":"Ciriacks","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2021.09.008_bib29","first-page":"387","article-title":"Myotonia atrophica and multiple calcifying epithelioma of Malherbe","volume":"45","author":"Cantwell","year":"1965","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.jdin.2021.09.008_bib30","first-page":"2009","article-title":"Hypothesis: neoplasms in myotonic dystrophy","volume":"20","author":"Mueller","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.jdin.2021.09.008_bib31","doi-asserted-by":"crossref","DOI":"10.5070\/D32212033380","article-title":"Multiple pilomatricomas in the setting of myotonic dystrophy","volume":"22","author":"Park","year":"2016","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib32","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/ced.13946","article-title":"Multiple pilomatrixomas as a presentation of myotonic dystrophy","volume":"44","author":"Kentley","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib33","doi-asserted-by":"crossref","first-page":"e0230003","DOI":"10.1371\/journal.pone.0230003","article-title":"Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype","volume":"15","author":"R\u00fcbben","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jdin.2021.09.008_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0303-6987.2005.00267.x","article-title":"Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding \u03b2-catenin","volume":"32","author":"Lazar","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/7747","article-title":"A common human skin tumour is caused by activating mutations in \u03b2- catenin","volume":"21","author":"Chan","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-2133.2001.04455.x","article-title":"\u03b2-catenin expression in pilomatrixomas. Relationship with \u03b2-catenin gene mutations and comparison with \u03b2-catenin expression in normal hair follicles","volume":"145","author":"Moreno-Bueno","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2021.09.008_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nmd.2016.11.004","article-title":"Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin D homeostasis","volume":"27","author":"Campione","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"48","key":"10.1016\/j.jdin.2021.09.008_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013448","article-title":"Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: a case report","volume":"97","author":"Portaro","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jdin.2021.09.008_bib39","first-page":"226","article-title":"Multiple basaliomas in Curschmann\u2013Steinert myotonia atrophica. Article in German","volume":"37","author":"Stieler","year":"1986","journal-title":"Hautarzt"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib40","doi-asserted-by":"crossref","first-page":"e227233","DOI":"10.1136\/bcr-2018-227233","article-title":"Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1","volume":"12","author":"Feng","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.jdin.2021.09.008_bib41","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ijc.31143","article-title":"Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the UK Clinical Practice Research Datalink","volume":"142","author":"Wang","year":"2018","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jdin.2021.09.008_bib42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1159\/000456074","article-title":"Cutaneous neoplasms in myotonic dystrophy type 1","volume":"232","author":"Marcoval","year":"2016","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mus.26194","article-title":"Cancer phenotype in myotonic dystrophy patients: results from a meta-analysis","volume":"58","author":"Emparanza","year":"2018","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jdin.2021.09.008_bib44","doi-asserted-by":"crossref","first-page":"pky052","DOI":"10.1093\/jncics\/pky052","article-title":"Cancer risk in myotonic dystrophy type I: evidence of a role for disease severity","volume":"2","author":"Alsaggaf","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"3","key":"10.1016\/j.jdin.2021.09.008_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00415-015-8006-y","article-title":"Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors","volume":"263","author":"Bianchi","year":"2016","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jdin.2021.09.008_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/mus.25736","article-title":"Benign and malignant tumors in the UK myotonic dystrophy patient registry","volume":"57","author":"Alsaggaf","year":"2018","journal-title":"Muscle Nerve"},{"issue":"64","key":"10.1016\/j.jdin.2021.09.008_bib47","doi-asserted-by":"crossref","first-page":"108195","DOI":"10.18632\/oncotarget.22598","article-title":"The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target","volume":"8","author":"Meta","year":"2017","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.jdin.2021.09.008_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24173175","article-title":"DMPK is a new candidate mediator of tumor suppressor p53-dependent cell death","volume":"24","author":"Itoh","year":"2019","journal-title":"Molecules"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:14Z","timestamp":1762981214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328721000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":48,"alternative-id":["S2666328721000778"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2021.09.008","relation":{},"ISSN":["2666-3287"],"issn-type":[{"type":"print","value":"2666-3287"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous findings in myotonic dystrophy","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}